comparemela.com

Latest Breaking News On - Peter droc - Page 1 : comparemela.com

Lonza to enhance commercial ADC supply capacity

Lonza to enhance commercial ADC supply capacity
europeanpharmaceuticalreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from europeanpharmaceuticalreview.com Daily Mail and Mail on Sunday newspapers.

Switzerland
Visp
Switzerland-general
Peter-droc
Lonza-stein
Taljat-david-shutterstock
Drug-product-services
Head-of-drug-product-services-at-lonza
Taljat-david

Lonza Announces New Filling Line for Commercial Supply of Antibody-Drug Conjugates for a Dedicated C

Lonza Group AG / Key word(s): ExpansionLonza Announces New Filling Line for Commercial Supply of Antibody-Drug Conjugates for a Dedicated Customer 13.10.2023 / 08:00 CET/CEST The new cGMP filling line at Lonza’s Stein (CH) site will enable handling and filling of bioconjugates for commercial supply Expansion of fill.

Switzerland
Singapore
Visp
Switzerland-general
Swiss
Lyle-wheeler
Peter-droc
Lonza-bioconjugation
Head-of-drug-product-services
Lonza-group-ag-key
Lonza-group-ltd
Swiss-exchange

Lonza drug product manufacturing line in Visp is operational

Swiss CDMO Lonza has increased capacity and capabilities at its Visp, Switzerland site, with the completion of a new line for cGMP clinical and commercial drug product manufacturing.

Switzerland
Visp
Switzerland-general
Peter-droc
Bio-developments
Monza
Dmo
Isp
Drug-substances

Lonza Completes Clinical and Commercial Drug Product Manufacturing Line in Visp (CH)

Lonza Group AG / Key word: Expansion Lonza Completes Clinical and Commercial Drug Product Manufacturing Line in Visp 29.03.2023 / 09:00 CET/CEST Lonza increases capacity and. | March 29, 2023

Switzerland
Visp
Switzerland-general
Peter-droc
Drug-product-services
Technology-park
Head-of-drug-product-services
Lonza-drug-product-center
Drug-product-center
Lonza-group-ag-stock-exchange
News
Information

Licensing Agreement to Drive Multi-specific Biotherapeutics Development

Zhejiang Doer Biologics Co, Ltd and Lonza have entered into a research license agreement for Doer Biologics to use Lonza’s XS Technologies® offering for production of its proprietary MultipleBody® and SMART-VHHBody platform technology. Click to read more.

Yanshan-huang
Peter-droc
Drug-product-services
Zhejiang-doer-biologics-co-ltd
Doer-biologics
Doer-biologic
Pichia-expression-system
Expression-system
Doer
Iologics
Ulti
Specific

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.